Eliyahu Sharon Kalif - Mar 4, 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Financial Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif
Stock symbol
TEVA
Transactions as of
Mar 4, 2025
Transactions value $
$0
Form type
4
Date filed
3/6/2025, 04:13 PM
Previous filing
Mar 4, 2025
Next filing
Mar 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +33.5K +16.95% 231K Mar 4, 2025 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +23.3K +10.05% 255K Mar 4, 2025 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +183K +71.97% 438K Mar 4, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -33.5K -50% $0.00 33.5K Mar 4, 2025 Ordinary Shares 33.5K Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise $0 -23.3K -25% $0.00 69.8K Mar 4, 2025 Ordinary Shares 23.3K Direct F1, F2, F4
transaction TEVA Restricted Share Units Options Exercise $0 -183K -100% $0.00 0 Mar 4, 2025 Ordinary Shares 183K Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 33,512 vesting on March 4, 2026.
F4 Restricted share units were granted on March 4, 2024, with 23,251 vested on March 4, 2025, 23,251 vesting on each of March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028.
F5 Restricted share units were granted on January 28, 2025 pursuant to the satisfaction of performance criteria and vested on March 4, 2025.